Search
This Clinical Puzzle article describes our current knowledge of chronic otitis media and the existing research models for this condition
We aim to determine the contribute of bacteria and virus to childhood CAP to inform further development of effective strategies.
To identify and review key research advances from the literature published between 2019 and 2023 on the diagnosis and microbiology of otitis media (OM) including acute otitis media (AOM), recurrent AOM (rAOM), otitis media with effusion (OME), chronic suppurative otitis media (CSOM) and AOM complications (mastoiditis).
Nasopharyngeal colonisation with nontypeable Haemophilus influenzae (NTHi) is associated with development of infections including pneumonia and otitis media. The 10-valent pneumococcal conjugate vaccine (PCV10) uses NTHi Protein D (PD) as a carrier. Papua New Guinean children have exceptionally early and dense NTHi carriage, and high rates of NTHi-associated disease.
We have demonstrated that a single dose of a closely related commensal can delay onset of NTHi otitis media in vivo
These data provide evidence that otitis-prone children do not have impaired functional cell mediated immunity
We observed an association between Type III DNA methyltransferase presence and Otitis Media-associated middle ear isolates
Elevated antimicrobial proteins and peptides and cytokines in middle ear effusion are a marker of inflammation and bacterial persistence
Presence of bacterial otopathogen in the middle ear during ventilation tube insertion was a predictor of children at-risk of repeat ventilation tube insertion
The most urgent areas appear to be to continue monitoring the emergence of novel otopathogens, and the need to develop prevention and preventative therapies